
Nephrologist in the Land Below the Wind. Forever a Malaysian. @GlomCon fellow 2021. GlomCon Instructor
Joined February 2022
- Tweets174
- Following284
- Followers274
- Likes183
Benjamin Tan retweeted
🚨 We are pleased to announce the upcoming launch of GlomCon’s Rare Kidney Disease Journal, a new peer-reviewed journal developed in partnership with @SpringerNature. This journal will serve as a global platform dedicated to advancing research, clinical practice, and innovation in rare and complex kidney diseases.
Benjamin Tan retweeted
Pathogenesis of podocytopathies brilliantly elucidated at @GlomCon fellowship by @PRomagnani
Demand, reserve and regeneration
Benjamin Tan retweeted
Empowering the Next Generation of Nephrologists: Trainee Opportunities in #GlomCon's Educational Ecosystem ca. 2025 from @asnpublications @GlomCon @NWiegley @BetterCallSeeth @SaynaNorouzi @nephrologista @nikkonephro @poyanmehr
#Nephpearls
Graphic by @nikkonephro
👉 pubmed.ncbi.nlm.nih.gov/4110…
Benjamin Tan retweeted
A visual treat on Glomerular Pathology at @GlomCon virtual fellowship today🎓
First, Dr. Benjamin Popp on essentials of the kidney biopsy🔬
Next,a grand quiz-learning experience with Dr. @AnilaKurien!👇🏻Such a stunning spectrum of path images for the curriculum!
Par excellence!
Benjamin Tan retweeted
Great to meet @GlomCon senior mentors 🙏 and colleagues 👭👫!!#GlomconHawaii 2025
Benjamin Tan retweeted
Last day to submit your application today! 🚨
The Glomerular Disease Fellowship Program has graduated over 700 fellows worldwide, many of whom have launched new glomerular disease clinics, participated in groundbreaking clinical trials, and earned recognition as leaders and experts in the field.
Submit your applications here 👉 glomcon.org/fellowship
#GlomCon
Benjamin Tan retweeted
The GlomCon Glomerular Disease Fellowship is now accepting applications! 🤩
Make sure you don't miss out on the chance to apply for the program and have the amazing opportunity to learn from top experts in the field and engage in interactive workshops with them.
Join the @GlomCon family by applying today!
🔗 Learn more: glomcon.org/fellowship
#GlomCon
Benjamin Tan retweeted
A thought provoking session on pregnancy & Glomerular disease at @GlomCon Fellowship today👇🏻
With Dr. Arpita Lahiri at the helm, delivering a comprehensive talk💯
Further co-steered by @divyaa24 @MayuriTrivedi80
Full of practical insights & tips on management of Glomerular disorders in pregnancy ✍🏻
@nephrologista
Benjamin Tan retweeted
🚨 Great news for our patients with IgA nephropathy:
Novartis receives FDA accelerated approval for atrasentan, a selective endothelin A receptor antagonist
novartis.com/us-en/news/medi…
Benjamin Tan retweeted
Pearls from Prof Arvind Bagga's lecture today @GlomCon
📌 The revised definition of FRNS in children
📌 Limit steroid exposure!
📌 Strategies to reduce relapse after Rituximab therapy
📌Genetic causes of SRNS
Benjamin Tan retweeted
👨🏫Interesting session on Pediatric Nephrotic Syndrome by Dr Prof Arvind Bagga @GlomCon fellowship
📍Indications for kidney biopsy in children:
1.Gross hematuria, persistent microscopic hematuria
2.Sustained hypertension
3.Acute kidney injury not attributed to hypovolemia Systemic features: fever, rash, arthralgia, low C3
4.Steroid resistant nephrotic syndrome
Benjamin Tan retweeted
At @GlomCon Podocin on AAV with @BrixSilke, Lani Sochet, Prof Soo Kun Lim and Min Hui Tan as we delved into the current gaps in delivering personalised and precision medicine in AAV. We need better prediction tools, less use of steroids, more targeted therapies with less AEs.
Benjamin Tan retweeted
Registration is now open for GlomCon Hawaii! 🌴🌊🌸
Join us from September 22‑25 for another year of insightful education, innovative research, and productive collaboration in paradise. Register now at 👉 glomconhawaii.org
This year’s in-person gathering promises to strengthen connections, spark deeper collaboration, and elevate the learning experience in beautiful Hawaii.
Learn more about the conference here: bit.ly/glomconhawaii-about
Can't join us in person? We plan to live-stream the main sessions; see you on the virtual side.
#GlomConHawaii
#GlomCon
Benjamin Tan retweeted
𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the ISN Oceania and South East Asia Regional Board Webinar: "Innovations in Nephrology Education"
🗣️ @nephrologista, @nephromythri
👤 @NephBen
🗓️ November 8
🕚 9:30 am CET
🔗 Free registration: ow.ly/JQOh50TKXAl
Benjamin Tan retweeted
Sneak peek into a wonderful session by Dr Russell Villanueva, Philippines on “Epidemiology of glomerular disease from Southeast Asia” @glomcon fellowship
🌎The incidence of CKD ⬆️
🍬M/c cause - DM
🇮🇳India has 1 nephrologist for 1.5 million population
Benjamin Tan retweeted
Delighted to share our chapter on IRGN in #GlomPedia a newly released continuously updated e-book on Glomerular disease by @GlomCon
Co-authors: @vjha126 @kidneypathology @Alexgr23
Thanks to @sonia_rgzr for carrying through!
Free download on the Apple App Store Google Play 👉
Benjamin Tan retweeted
Join GlomCon this Sunday:
Biopsy or Not Biopsy in Patients with Diabetes and Kidney Disease by Dr. Maria Jose Soler
ID: 875 5077 1266
Passcode 202122
sign up 👉🏻 my.glomcon.org
#GlomCon
Benjamin Tan retweeted
📖 This weekend don't miss our @KIReports #ISNFridaySelection: Key points in managing PLA2R-associated membranous nephropathy kireports.org/article/S2468-…
Benjamin Tan retweeted
The Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) from @goKDIGO is out for public review ‼️
#KDIGOIgAN #Nephpearls
📌 Submit comments by Sept 30 🗓️
👉 kdigo.org/guidelines/iga-nep… – at Riverside, IL
Benjamin Tan retweeted
🚨 3 DAYS left to apply!
Join the @GlomCon family by applying today 👉 glomcon.org/fellowship
#nephtwitter #medtwitter
Make sure you don't miss out on the chance to apply for the GlomCon Fellowship program.
By participating, you'll have the amazing opportunity to learn from top experts in the field and engage in interactive workshops with them.
Join the @GlomCon family by applying today!
#nephtwitter #medtwitter
👉🏻 glomcon.org/fellowship









































